Subthalamic nucleus deep brain stimulation improves sleep in Parkinson's disease patients: a retrospective study and a meta-analysis

Sleep Med. 2020 Oct:74:301-306. doi: 10.1016/j.sleep.2020.07.042. Epub 2020 Aug 10.

Abstract

Background: Most Parkinson's patients suffered from sleep problems. There is increasing evidence that Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) has a positive effect on several sleep parameters, improving overall sleep quality in patients with PD. However, the results are controversial.

Methods: We performed a retrospective study and meta-analysis to assess the Parkinson's disease sleep scale (PDSS) in Parkinson's patients.

Results: We reviewed our data of patients who underwent STN-DBS, and then extracted five other trials to perform a meta-analysis. The pooled results showed an advantage on post-operative PDSS in both our medical center and pooled results (MD = 20.41, 95% CI = [13.03, 27.79], I2 = 61%, P < 0.001). There was a significant difference in Unified Parkinson's Disease Rating Scale (UPDRS)-Ⅲ score between pre and post-operation (MD = -12.59, 95% CI = [-14.70, -10.49], I2 = 90%, P < 0.001). What's more, Parkinsonian medication was significantly lower in the post-operative groups after DBS (MD = -314.71, 95% CI = [-468.13, -161.28], I2 = 53%, P < 0.001).

Conclusion: In the retrospective study and meta-analysis of 6 trials, we found that DBS can significantly increase sleep quality. Furthermore, motor function improved and Parkinsonian medication was significantly decreased postoperatively. The sample size was enough and no further investigations would change the conclusion.

Keywords: DBS; Meta-analysis; PDSS; Parkinson's disease; STN; Sleep quality.

Publication types

  • Meta-Analysis

MeSH terms

  • Deep Brain Stimulation*
  • Humans
  • Parkinson Disease* / complications
  • Parkinson Disease* / therapy
  • Retrospective Studies
  • Sleep
  • Subthalamic Nucleus*
  • Treatment Outcome